Latest Articles
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - Business Wire
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen Business Wire
Published: Oct. 18, 2025, 10 a.m.
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer - geneonline.com
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer geneonline.com
Published: Oct. 14, 2025, 6:39 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - Bioengineer.org
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival Bioengineer.org
Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - BIOENGINEER.ORG
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival BIOENGINEER.ORG
Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - bioengineer.org
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival bioengineer.org
Published: Oct. 14, 2025, 5:14 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org
Published: Oct. 14, 2025, 4:49 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG
Published: Oct. 14, 2025, 4:49 p.m.
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer - CancerNetwork
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer CancerNetwork
Published: Oct. 13, 2025, 10:05 p.m.
Researchers awarded $11.2M grant to close endometrial cancer survival gap - UNC Gillings School of Global Public Health
Researchers awarded $11.2M grant to close endometrial cancer survival gap UNC Gillings School of Global Public Health
Published: Oct. 9, 2025, 4:10 p.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 - BioSpace
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 BioSpace
Published: Oct. 3, 2025, 10:53 a.m.
Link copied to clipboard!